[go: up one dir, main page]

GB201706226D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB201706226D0
GB201706226D0 GBGB1706226.6A GB201706226A GB201706226D0 GB 201706226 D0 GB201706226 D0 GB 201706226D0 GB 201706226 A GB201706226 A GB 201706226A GB 201706226 D0 GB201706226 D0 GB 201706226D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1706226.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1706226.6A priority Critical patent/GB201706226D0/en
Publication of GB201706226D0 publication Critical patent/GB201706226D0/en
Priority to ES18719162T priority patent/ES2977788T3/en
Priority to AU2018253948A priority patent/AU2018253948B2/en
Priority to EP18719162.2A priority patent/EP3612234B1/en
Priority to JP2019556986A priority patent/JP7408396B2/en
Priority to CN201880025195.1A priority patent/CN110536703B/en
Priority to US16/605,692 priority patent/US20200129637A1/en
Priority to MX2019012464A priority patent/MX2019012464A/en
Priority to BR112019021880-7A priority patent/BR112019021880A2/en
Priority to KR1020197030286A priority patent/KR20190141666A/en
Priority to CA3057748A priority patent/CA3057748A1/en
Priority to PL18719162.2T priority patent/PL3612234T3/en
Priority to NZ756730A priority patent/NZ756730A/en
Priority to PCT/EP2018/060209 priority patent/WO2018193102A1/en
Priority to US16/197,891 priority patent/US10544223B2/en
Priority to ZA2019/05727A priority patent/ZA201905727B/en
Ceased legal-status Critical Current

Links

GBGB1706226.6A 2017-04-20 2017-04-20 Combination therapy Ceased GB201706226D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GBGB1706226.6A GB201706226D0 (en) 2017-04-20 2017-04-20 Combination therapy
PCT/EP2018/060209 WO2018193102A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-axl antibody-drug conjugate
US16/605,692 US20200129637A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-axl antibody-drug conjugate
BR112019021880-7A BR112019021880A2 (en) 2017-04-20 2018-04-20 COMBINATION THERAPY WITH ANTI-AXL-DRUG ANTIBODY CONJUGATE
EP18719162.2A EP3612234B1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-axl antibody-drug conjugate
JP2019556986A JP7408396B2 (en) 2017-04-20 2018-04-20 combination therapy
CN201880025195.1A CN110536703B (en) 2017-04-20 2018-04-20 Combination therapy using anti-AXL antibody-drug conjugates
ES18719162T ES2977788T3 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-AXL antibody-drug conjugate
MX2019012464A MX2019012464A (en) 2017-04-20 2018-04-20 Combination therapy with an anti-axl antibody-drug conjugate.
AU2018253948A AU2018253948B2 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-AXL Antibody-Drug Conjugate
KR1020197030286A KR20190141666A (en) 2017-04-20 2018-04-20 Combination Therapy with Anti-AXL Antibody-Drug Conjugates
CA3057748A CA3057748A1 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-axl antibody-drug conjugate
PL18719162.2T PL3612234T3 (en) 2017-04-20 2018-04-20 Combination therapy with an anti-axl antibody-drug conjugate
NZ756730A NZ756730A (en) 2017-04-20 2018-04-20 Combination therapy with an anti-axl antibody-drug conjugate
US16/197,891 US10544223B2 (en) 2017-04-20 2018-11-21 Combination therapy with an anti-axl antibody-drug conjugate
ZA2019/05727A ZA201905727B (en) 2017-04-20 2019-08-30 Combination therapy with an anti-axl antibody-drug conjugate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1706226.6A GB201706226D0 (en) 2017-04-20 2017-04-20 Combination therapy

Publications (1)

Publication Number Publication Date
GB201706226D0 true GB201706226D0 (en) 2017-06-07

Family

ID=58795612

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1706226.6A Ceased GB201706226D0 (en) 2017-04-20 2017-04-20 Combination therapy

Country Status (1)

Country Link
GB (1) GB201706226D0 (en)

Similar Documents

Publication Publication Date Title
PT3618875T (en) Combination therapy
IL272560A (en) Combination therapy
GB201713914D0 (en) Combination therapy
GB201713113D0 (en) Combination therapy
GB201706243D0 (en) Combination therapy
GB201706239D0 (en) Combination therapy
GB201706225D0 (en) Combination therapy
GB201706227D0 (en) Combination therapy
GB201706228D0 (en) Combination therapy
GB201706229D0 (en) Combination therapy
GB201706230D0 (en) Combination therapy
GB201706231D0 (en) Combination therapy
GB201706232D0 (en) Combination therapy
GB201706233D0 (en) Combination therapy
GB201706234D0 (en) Combination therapy
GB201706235D0 (en) Combination therapy
GB201706236D0 (en) Combination therapy
GB201706248D0 (en) Combination therapy
GB201706238D0 (en) Combination therapy
GB201706247D0 (en) Combination therapy
GB201706240D0 (en) Combination therapy
GB201706241D0 (en) Combination therapy
GB201706242D0 (en) Combination therapy
GB201706223D0 (en) Combination therapy
GB201706244D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)